The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 20, 2016
Filed:
May. 29, 2012
Applicant:
Paolo Pevarello, Pavia, IT;
Inventor:
Paolo Pevarello, Pavia, IT;
Assignee:
NEWRON PHARMACEUTICALS S.P.A., Bresso (MI), IT;
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07C 237/06 (2006.01); C07D 277/24 (2006.01); A61K 31/426 (2006.01); C07D 209/08 (2006.01); C07D 217/06 (2006.01); C07D 265/36 (2006.01); C07D 295/182 (2006.01); C07D 295/185 (2006.01); C07C 237/14 (2006.01); C07C 237/20 (2006.01); A61K 31/165 (2006.01); A61K 31/397 (2006.01); A61K 31/40 (2006.01); A61K 31/4453 (2006.01); A61K 31/47 (2006.01); A61K 31/495 (2006.01); A61K 31/5375 (2006.01); A61K 31/538 (2006.01); C07D 205/04 (2006.01); C07D 207/06 (2006.01);
U.S. Cl.
CPC ...
C07C 237/06 (2013.01); A61K 31/165 (2013.01); A61K 31/397 (2013.01); A61K 31/40 (2013.01); A61K 31/426 (2013.01); A61K 31/4453 (2013.01); A61K 31/47 (2013.01); A61K 31/495 (2013.01); A61K 31/538 (2013.01); A61K 31/5375 (2013.01); C07C 237/14 (2013.01); C07C 237/20 (2013.01); C07D 205/04 (2013.01); C07D 207/06 (2013.01); C07D 209/08 (2013.01); C07D 217/06 (2013.01); C07D 265/36 (2013.01); C07D 277/24 (2013.01); C07D 295/182 (2013.01); C07D 295/185 (2013.01); C07C 2101/14 (2013.01);
Abstract
Fluorinated arylalkylaminocarboxamide derivatives of formula (I) are described wherein W, J, n, R, R, R, R, Rand Rhave the meanings as defined in the specification and pharmaceutically salts thereof, pharmaceutical compositions containing them as active ingredients and their use as sodium and/or calcium channel modulators useful in preventing, alleviating and curing a wide range of pathologies, including neurological, psychiatric, cardiovascular, inflammatory, ophthalmic, urological, and gastrointestinal diseases, where the above mechanisms have been described as playing a pathological role.